financetom
Business
financetom
/
Business
/
Calfrac Well Services Q2 Net Income Falls; Reduces Operating Footprint in North America
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Calfrac Well Services Q2 Net Income Falls; Reduces Operating Footprint in North America
Aug 8, 2025 4:28 AM

07:15 AM EDT, 08/08/2025 (MT Newswires) -- Calfrac Well Services ( CFWFF ) on Friday reported a decline in second-quarter net income, citing the "current macroeconomic challenges affecting the global economy", and said it had recently taken steps to reduce its operating footprint in North America.

Net income was $15.3 million, or $0.18 per share, down from $24.5 million, or $0.29 per share, primarily due to an increase in current taxes arising from the improved profitability in Argentina which has a higher effective tax rate.

Calfrac generated Adjusted EBITDA of $77.0 million during the second quarter in 2025, a 39% increase from the first quarter in 2025, primarily due to improved utilization and financial performance in North America. The company's Argentina operations also delivered "another very strong quarter", building on the positive momentum from its record first-quarter.

Revenue amounted to $402.3 million, down from $426 million mainly due to lower activity and pricing in North America.

Calfrac's Chief Financial Officer, Mike Olinek, said: "The company's second unconventional fracturing fleet in Argentina continues to gain further traction and we are excited about our ability to capture future growth opportunities in that market."

He added: "Calfrac has recently taken steps to reduce its operating footprint in North America to 10 fleets as customer activity is expected to soften in the second half of the year, but I am confident that the demand for our next-generation Dynamic Gas Blending fleets will continue to remain strong. The completion of the company's North American fleet modernization program during the second quarter combined with normal seasonality is expected to result in robust cash flow throughout the remainder of the year which will be used to reduce long-term debt."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Walker & Dunlop Plans $400 Million Senior Notes Offering
Walker & Dunlop Plans $400 Million Senior Notes Offering
Mar 3, 2025
09:01 AM EST, 03/03/2025 (MT Newswires) -- Walker & Dunlop ( WD ) said Monday it intends to offer $400 million in senior unsecured notes due 2033 through a private placement. In conjunction with the notes offering, the company said it plans to amend and restate its senior secured term loan agreement, reducing the outstanding loans to $450 million, extending...
Generation Mining Secures Additional Permit Approvals for Marathon Copper-Palladium Project in Ontario
Generation Mining Secures Additional Permit Approvals for Marathon Copper-Palladium Project in Ontario
Mar 3, 2025
08:51 AM EST, 03/03/2025 (MT Newswires) -- Generation Mining ( GENMF ) said Monday that it received two additional permits for the Marathon copper-palladium project in Ontario. The company secured a permit to take water from the Ministry of the Environment, Conservation and Parks (MECP). This is one of the four approvals for the Lakes and Rivers Improvement Act permit,...
Valley National Bancorp Names Travis Lan Finance Chief
Valley National Bancorp Names Travis Lan Finance Chief
Mar 3, 2025
09:01 AM EST, 03/03/2025 (MT Newswires) -- Valley National Bancorp ( VLY ) said Monday it has named Travis Lan as chief financial officer, a position he has held on an interim basis. The company also appointed Gino Martocci as president of Commercial Banking. He succeeds Joe Chillura, who is leaving the company effective June 30. Martocci previously served as...
Protagonist, Takeda Say Phase 3 Study of Rusfertide Meets Endpoints in Polycythemia Vera
Protagonist, Takeda Say Phase 3 Study of Rusfertide Meets Endpoints in Polycythemia Vera
Mar 3, 2025
09:00 AM EST, 03/03/2025 (MT Newswires) -- Protagonist Therapeutics ( PTGX ) and Takeda (TAK) said Monday that a phase 3 study of investigational drug rusfertide as a potential add-on to standard of care treatment for polycythemia vera, a form of blood cancer, met the primary and key secondary endpoints. The companies said Protagonist will earn a milestone payment of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved